임신부의 의약품 사용 현황 및 의약품 안전사용 교육을 위한 교재개발
Medication Utilization during Pregnancy and Development of Educational Materials for Safe Use of Medication
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
본 연구에서는 임신부의 약물복용 현황 및 교육 요구 도를 조사하여 올바른 정보전달을 위한 교육교재를 개발하고자 하였다. 임신부를 대상으로 의약품 안전사용 교육 경험을 조사한 결과 97.4%의 임신부가 경험이 없었으며, 90.1%가 의약품 안전사용에 관한 교육이 필요 하다고 인식하고 있어 본 교재개발이 적절했음을 시사 하였다. 약물에 관한 안전성 및 위험성 정보는 의사, 약사에게서 얻는 경우가 많았으며, 임신 중 의약품 복용시 궁금한 사항으로는 약물노출로 인한 선천성 기형유발 및 임신부에 대한 악물유해반응이 가장 높았고 선호 하는 교육자료 형태는 개별 복약지도용 리플릿이었다. 개발된 교육자료의 현장 시범교육을 통해 임신부의 95 % 이상이 만족하였다고 응답하였으며 91% 이상이 약물복용의 올바른 이해에 도움이 되었다는 평가를 받았 다.
Abstract
Purpose: This study aimed to investigate the safe medication utilization and the education demands during pregnancy and it further reported the development of educational materials for pregnant women. Methods: A survey was conducted in two tertiary care university hospitals and one community hospital specialized in obstetrics and gynecology from July 2 to 29 2014. The survey questionnaires included the usage of medications and the unmet needs on medication use during pregnancy. Ad ditionally, pregnant women’s requests regarding to medication use were collected through group interviewing of community pharmacists. Based on these results, educational materials were de veloped and implemented. After implementing the education sessions, the satisfaction was evaluated. Results: A total of 152 pregnant women answered completely the questionnaire. Among them, 130 participants (42.8%) were given the medication information from their physicians. Exposure to a teratogenic drug during pregnancy was a major concern for most pregnant women (79.6%). The majority (90.1%) of subjects reported a necessity of medication-related education during their pregnancy. The interview with 48 pharmacists indicated that the most commonly used OTC drugs in pregnancy were vitamins (25.2%), iron supplements (23.7%), and the most frequently used prescription drugs were antiinflammatory-analgesics (25.3%), followed by antibiotics (20.9 %). Based on the results, booklets of drug therapy during pregnancy, leaflet of pregnancy category index were made. Also, on-line flash and presentation materials for instructors were prepared. Through the trial education with the developed materials, it was confirmed that the contents of education materials were well understood and satisfied by the pregnant women. Conclusions: This study showed the need of the medication-related education for the pregnant women. The developed education materials would be helpful sources to provide accurate and reliable medication-related information to health professionals and pregnant women.
참고문헌 (31)
- Addis A, "Risk classification systems for drug use during pregnancy - are they a reliable source of information?", Drug Saf, 23(3), pp.245~253 (2000)
- Andrade SE, "Use of prescription medications with a potential for fetal harm among pregnant women", Pharmacoepidemiol Drug Saf, 15(8), pp.546~554 (2006)
- Bakhireva LN, "Patient utilization of information sources about safety of medications during pregnancy", J Reprod Med, 56(7-8), pp.339~343 (2011)
- Bakker MK, "Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancyrelated drugs in the Netherlands", BJOG-Int J Obstet Gy, 113(5), pp.559~568 (2006)
- Bonari L, "Use of antidepressants by pregnant women: evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making", Arch Women’s Ment Health, 8(4), pp.214~220 (2005)
- 차명일, "일개 3차병원 응급의료센터의 가임기 여성에 대한 기형유발가능약제 처방현황", 대한응급의학회지, 19(5), pp.582~587 (2008), 대한응급의학회
- 최준식, "임신초기 약물노출 후 임신결과; 10년간의 경험 - 생식 발생 독성 정보 활용화 방안 연구 -", Perinatology, 21(1), pp.48~58 (2010), 대한주산의학회
- Dunlop AL, "The clinical content of preconception care: women with chronic medical conditions", Am J Obstet Gynecol, 199(6), pp.S310~S327 (2008)
- Feibus KB, "FDA’s proposed rule for pregnancy and lactation labeling: improving maternal child health through well-informed medicine use", J Med Toxicol, 4(4), pp.284~288 (2008)
- "NPS Medicinewise" (2012)[URL]
- Han JY, "Unintended pregnancies and exposure to potential human teratogens", Birth Defects Res A Clin Mol Teratol, 73(4), pp.245~248 (2005)
- 한정열, "임신 제일삼분기 약물 및 진단용 방사선 노출 임신부에서 기형 발생 위험에 관한 근거중심적 상담의 효과", Obstetrics & Gynecology Science, 45(1), pp.133~138 (2002), 대한산부인과학회
- Hämeen-Anttila K, "Medicines information needs during pregnancy: a multinational comparison", BMJ Open, 3(4), pp.e002594~ (2013)
- Hardy JR, "Safety of medications prescribed before and during early pregnancy in a cohort of 81975 mothers from the UK general practice research database", Pharmacoepidemiol Drug Saf, 15(8), pp.555~564 (2006)
- Jacobsson B, "Advanced maternal age and adverse perinatal outcome", Obstet Gynecol, 104(4), pp.727~733 (2004)
- Kim MH, "Factors associated with a positive intake of folic acid in the periconceptional period among Korean women", Public Health Nutr, 12(4), pp.468~471 (2009)
- Korea Food and Drug Administration, "Study for application of reproductive toxicity information. 2008Koren G, Pastuszak A, Ito S. Drug therapy - drugs in pregnancy", New Engl J Med, 338(16), pp.1128~1137 (1998)
- Lagan BM, "Internet use in pregnancy informs women's decision making: a web based survey", Birth, 37(2), pp.106~115 (2010)
- Preconception care and policy recommendations collaborative report 2014-1-1, "Lee SL", Korea Institute for Health and Social Affairs, ~ (2014)
- Ministry of Food and Drug Safety, "Developing educational materials for safe use of medicines among adolescents and the elderly", ~ (2013)
- Mitchell AA, "Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008", Am J Obstet Gynecol, 205(1), pp.51.e1~51.e8 (2011)
- Montan S, "Increased risk in the elderly parturient", Curr Opin Obstet Gynecol, 19(2), pp.110~112 (2007)
- Nordeng H, "Perception of risk regarding the use of medications and other exposures during pregnancy", Eur J Clin Pharmacol, 66(2), pp.207~214 (2010)
- 유기연, "임산부의 약물 인식 및 복약 순응도 조사연구", 한국임상약학회지, 23(3), pp.197~205 (2013), 한국임상약학회
- Sanz E, "Perception of teratogenic risk of common medicines", Eur J Obstet Gynecol Reprod Biol, 95(1), pp.127~131 (2001)
- Singh S, "Unintended pregnancy:worldwide levels, trends, and outcomes", Stud Fam Plann, 41(4), pp.241~250 (2010)
- "Statistics Korea" (2014)[URL]
- Walfisch A, "Perception of teratogenic risk and the rated likelihood of pregnancy termination: association with maternal depression", Can J Psychiatry, 56(12), pp.761~767 (2011)
- 왕희정, "고령임부와 35세 미만 임부의 산전 건강관리 실태와교육요구 비교", 여성건강간호학회지, 19(4), pp.230~241 (2013), 여성건강간호학회
- Yang T, "Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population", Pharmacoepidemiol Drug Saf, 17(3), pp.270~277 (2008)
- 윤순정, "약물복용 임부의 우울에 영향을 미치는 요인", 한국모자보건학회지, 18(2), pp.273~285 (2014), 한국모자보건학회